Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Lorefice

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|April 5, 2020
Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing-Remitting and Primary Progressive Multiple SclerosisFederica Murgia, Lorena Lorefice, Simone Poddighe, et al.
Bioengineering (Basel, Switzerland)|February 23, 2024
Cybersickness in People with Multiple Sclerosis Exposed to Immersive Virtual RealityMassimiliano Pau, Federico Arippa, Bruno Leban, et al.
Frontiers in Neurology|September 20, 2021
The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical UtilityLorena Lorefice, Elisa Casaglia, Marzia Fronza, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measureMassimiliano Pau, Silvia Caggiari, Alessandro Mura, et al.
Multiple Sclerosis and Related Disorders|February 8, 2026
Reduced retinal neuronal injury as a consequence of high efficacy DMT treatment: an OCT studyAntonio Francesco Vacca, Su-Chun Huang, Elisa Idini, et al.
Neurology|December 8, 2017
PML in a person with multiple sclerosis: Is teriflunomide the felon?Lorena Lorefice, Giuseppe Fenu, Simonetta Gerevini, et al.
Journal of Proteomics|August 8, 2018
Top-down proteomic profiling of human saliva in multiple sclerosis patientsBarbara Manconi, Barbara Liori, Tiziana Cabras, et al.
Metabolites|March 29, 2023
Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with FingolimodFederica Murgia, Lorena Lorefice, Antonio Noto, et al.
BMC Neurology|November 19, 2013
What do multiple sclerosis patients and their caregivers perceive as unmet needs?Lorena Lorefice, Gioia Mura, Giulia Coni, et al.
Frontiers in Neurology|August 21, 2023
Menopausal transition in multiple sclerosis: relationship with disease activity and brain volume measurementsLorena Lorefice, Giuseppe Fenu, Marzia Fronza, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|April 5, 2020
Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing-Remitting and Primary Progressive Multiple SclerosisFederica Murgia, Lorena Lorefice, Simone Poddighe, et al.
Bioengineering (Basel, Switzerland)|February 23, 2024
Cybersickness in People with Multiple Sclerosis Exposed to Immersive Virtual RealityMassimiliano Pau, Federico Arippa, Bruno Leban, et al.
Frontiers in Neurology|September 20, 2021
The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical UtilityLorena Lorefice, Elisa Casaglia, Marzia Fronza, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measureMassimiliano Pau, Silvia Caggiari, Alessandro Mura, et al.
Multiple Sclerosis and Related Disorders|February 8, 2026
Reduced retinal neuronal injury as a consequence of high efficacy DMT treatment: an OCT studyAntonio Francesco Vacca, Su-Chun Huang, Elisa Idini, et al.
Neurology|December 8, 2017
PML in a person with multiple sclerosis: Is teriflunomide the felon?Lorena Lorefice, Giuseppe Fenu, Simonetta Gerevini, et al.
Journal of Proteomics|August 8, 2018
Top-down proteomic profiling of human saliva in multiple sclerosis patientsBarbara Manconi, Barbara Liori, Tiziana Cabras, et al.
Metabolites|March 29, 2023
Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with FingolimodFederica Murgia, Lorena Lorefice, Antonio Noto, et al.
BMC Neurology|November 19, 2013
What do multiple sclerosis patients and their caregivers perceive as unmet needs?Lorena Lorefice, Gioia Mura, Giulia Coni, et al.
Frontiers in Neurology|August 21, 2023
Menopausal transition in multiple sclerosis: relationship with disease activity and brain volume measurementsLorena Lorefice, Giuseppe Fenu, Marzia Fronza, et al.
Pageof 10